Globe Life (GL) EVP Dolores Skarjune Sells $331K of Stock
Globe Life's EVP Dolores Skarjune sold 1,850 shares worth $331,483.
Reviewed by automated data checks against the source filing. How we make and check alerts
Dolores Skarjune, EVP and Chief Admin. Officer at Globe Life Inc. ($GL), sold 1,850 shares at an average price of $179.18, worth about $331,483, on June 30, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $GL is down 0.9% after 1 week, up 2.6% after 1 month and down 5.2% to date (from the $178 close on Jun 30, 2026).
Key Points
- Dolores Skarjune, EVP and Chief Admin. Officer at Globe Life, sold 1,850 shares for $331,483 on June 30, 2026.
- Globe Life, trading at $179.25, has a market cap of $13.92 billion with a P/E ratio of 12.41 and a beta of 0.499.
- Analysts maintain a 'buy' consensus with a target mean price of $177.36, as TD Cowen set a $215 target on June 23.
Get $GL trade alerts by text
We text you when insiders, Congress or big funds trade $GL. Free.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Globe Life Inc. alert may contain errors. Disclosures
Dolores Skarjune, the Executive Vice President and Chief Administrative Officer of Globe Life Inc., sold 1,850 shares of the company on June 30, 2026. The shares were sold at an average price of $179.18, totaling approximately $331,483. This transaction was not conducted under a pre-arranged trading plan.
Insider Buying and Selling at Globe Life Inc.
In addition to the recent sale by Dolores Skarjune, other insider transactions at Globe Life Inc. include Cheryl Alston's purchase of 14,017 shares at $105.56 and sale of 8,258 shares at $179.24 on June 25, 2026. These transactions were also not part of any pre-planned trading arrangements.
Globe Life Inc. Stock Up 3.0%
Shares of NYSE:GL traded near $179.25 on Tuesday. Globe Life Inc. has a market capitalization of $13.92 billion. The company sports a P/E ratio of 12.41 and a forward P/E of 10.77. The stock's beta is 0.499, indicating lower volatility compared to the market. Its 52-week low is $116.73, and its high is $181.15. The 50-day moving average is $157.81, while the 200-day moving average stands at $143.88.
Analysts Set New Price Targets
On June 23, 2026, TD Cowen maintained its 'buy' rating on Globe Life with a price target of $215. Other firms like Piper Sandler and Morgan Stanley also maintain 'buy' ratings, with targets of $175 and $181, respectively. The consensus among analysts is a 'buy' recommendation, with a mean target price of $177.36 based on 11 analyst opinions.
About Globe Life Inc.
Globe Life Inc. is a life insurance company headquartered in McKinney, Texas. It offers various life and supplemental health insurance products aimed at lower-middle and middle-income families in the United States. The company operates through segments like Life Insurance and Supplemental Health Insurance, selling its products through direct-to-consumer channels and independent agents. Globe Life, led by CEO Frank Martin Svoboda, employs approximately 3,695 people.
Bottom Line
Dolores Skarjune's recent sale of Globe Life shares is a notable insider transaction, though it does not necessarily signal a change in the company's outlook. Globe Life continues to trade strongly, with analysts maintaining a positive outlook and setting high price targets. Investors often monitor such insider transactions to gauge potential shifts in company sentiment, but it's essential to remember that these filings reflect past actions.
Source: Dolores Skarjune's Form 4 filing on $GL (Jun 30, 2026). Find the original filing: GL Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts